For example, TNFRSF11B exhibited a cancer-specific behaviour in ovarian cancer by contrast to breast, where it was found to be down-regulated and was proposed as a potential prognostic biomarker [57]. Here, TNFRSF11B is linked to ovarian carcinoma.